{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:15:08Z","timestamp":1788430508224,"version":"build-2803163510"},"reference-count":28,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012547","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2024GXNSFAA010114"],"award-info":[{"award-number":["2024GXNSFAA010114"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360538"],"award-info":[{"award-number":["82360538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82360538"],"award-info":[{"award-number":["82360538"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"project of improving the basic ability of scientific research of young and middle-aged teachers in Guangxi universities","award":["2022KY0083"],"award-info":[{"award-number":["2022KY0083"]}]},{"name":"first-class discipline innovation-driven talent program of Guangxi Medical University"},{"id":[{"id":"https:\/\/ror.org\/03dveyr97","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objectives: Nasopharyngeal carcinoma (NPC) arises in an immune-suppressive milieu that frequently undermines treatment efficacy. TPPP3 has been implicated as a negative regulator of NPC aggressiveness, yet its relevance to immune modulation or chaperone networks remains poorly defined. We therefore sought to determine how TPPP3 shapes the NPC immune landscape and to identify its interacting protein partners. Methods: Public single-cell RNA-sequencing datasets from head and neck squamous cell carcinoma and nasopharyngeal carcinoma were analyzed using R. HK-1 and C666-1 cells stably overexpressing TPPP3 were established. These cells were used to construct humanized xenograft tumor models, with intratumoral immune cell infiltration evaluated by immunohistochemistry. In vitro, the same cells and their controls were indirectly co-cultured with peripheral blood mononuclear cells. Cellular lysates from TPPP3-overexpressing cells were subjected to immunoprecipitation\u2013mass spectrometry and immunofluorescence staining, which identified HSPA8 as a TPPP3-interacting protein. Three groups\u2014control, TPPP3-overexpressing, and TPPP3-overexpressing plus the HSPA8 inhibitor VER155008\u2014were then compared in wound healing, colony formation, cell-cycle, and xenograft assays, with immunohistochemical staining for Ki67, TPPP3, and CD3 performed on tumor sections. Results: TPPP3 transcripts were barely detectable across most tumor cell subsets but showed preferential enrichment in NPC epithelial clusters. Enforced TPPP3 expression curtailed xenograft outgrowth while increasing intratumoral abundance of CD3+ T cells, CD8+ T cells, and CD11c+ dendritic cells. Pharmacological blockade of HSPA8 with VER155008 further enhanced TPPP3-driven suppression of migration, clonogenicity, and tumor expansion, and also altered cell-cycle progression while boosting CD3+ T-cell accumulation within grafts. Conclusions: These findings suggest a functional association between TPPP3 and HSPA8 that may contribute to tumor growth suppression and immune microenvironment remodeling in NPC. Pharmacological disruption of HSPA8-dependent proteostasis enhanced TPPP3-associated antitumor activity in both in vitro and in vivo models, indicating that this chaperone pathway represents a candidate mechanism worthy of further mechanistic investigation and therapeutic exploration.<\/jats:p>","DOI":"10.3390\/cancers18172851","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:20:43Z","timestamp":1788427243000},"page":"2851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TPPP3 Overexpression Suppresses Nasopharyngeal Carcinoma Progression and Promotes Immune Microenvironment Remodeling Through HSPA8 Association"],"prefix":"10.3390","volume":"18","author":[{"given":"Shengwei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Jiejun","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Jiawei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"}]},{"given":"Yanfeng","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Zixiao","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/anpc-21-12","article-title":"Utility of Epstein-Barr virus (EBV) antibodies as screening markers for nasopharyngeal carcinoma: A narrative review","volume":"6","author":"Sinha","year":"2022","journal-title":"Ann. Nasopharynx Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12967-024-05880-7","article-title":"Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: Tertiary lymphoid structures","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Su, Z.Y., Siak, P.Y., Leong, C.O., and Cheah, S.C. (2022). Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.840467"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ajco.70048","article-title":"Radiotherapy Planning for Nasopharyngeal Carcinoma After Induction Chemotherapy: A Systematic Review to Inform Consensus Guideline Development","volume":"22","author":"Nouri","year":"2025","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","article-title":"Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma","volume":"30","author":"Jin","year":"2020","journal-title":"Cell Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.crimmu.2022.08.009","article-title":"New insights into the tumour immune microenvironment of nasopharyngeal carcinoma","volume":"3","author":"Forder","year":"2022","journal-title":"Curr. Res. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-020-01292-5","article-title":"Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lord, J.W., and Horibata, S. (2025). Diverse Roles of Tubulin Polymerization Promoting Protein 3 (TPPP3) in Human Health and Disease. Cells, 14.","DOI":"10.20944\/preprints202509.1779.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3962146","DOI":"10.1155\/2020\/3962146","article-title":"TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.7150\/jca.14790","article-title":"Knockdown of Tubulin Polymerization Promoting Protein Family Member 3 Suppresses Proliferation and Induces Apoptosis in Non-Small-Cell Lung Cancer","volume":"7","author":"Li","year":"2016","journal-title":"J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1038\/s41598-023-45233-w","article-title":"TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma","volume":"13","author":"Xu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/1440-1681.13456","article-title":"TPPP3 inhibits the proliferation, invasion and migration of endometrial carcinoma targeted with miR-1827","volume":"48","author":"Shen","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cbf.3546","article-title":"Silence of TPPP3 suppresses cell proliferation, invasion and migration via inactivating NF-\u03baB\/COX2 signal pathway in breast cancer cell","volume":"38","author":"Ren","year":"2020","journal-title":"Cell Biochem. Funct."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.identj.2024.09.035","article-title":"TPPP3, a Good Prognostic Indicator, Suppresses Cell Proliferation and Migration in OSCC","volume":"75","author":"Xiao","year":"2025","journal-title":"Int. Dent. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1080\/21655979.2021.1984006","article-title":"Tubulin polymerization promoting protein family member 3 (TPPP3) overexpression inhibits cell proliferation and invasion in nasopharyngeal carcinoma","volume":"12","author":"Su","year":"2021","journal-title":"Bioengineered"},{"key":"ref_17","first-page":"990","article-title":"Research progress on the impact of heat shock protein family A member 8 on virus infection of host cells","volume":"66","author":"Li","year":"2026","journal-title":"Acta Microbiol. Sin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13062-024-00453-6","article-title":"RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination","volume":"19","author":"Zhang","year":"2024","journal-title":"Biol. Direct"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13577-025-01340-6","article-title":"HSPA8 promotes the progression of gastric cancer by activating the canonical Wnt pathway and glycolysis","volume":"39","author":"Shi","year":"2025","journal-title":"Hum. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","article-title":"HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.4161\/auto.26448","article-title":"HSPA8\/HSC70 chaperone protein: Structure, function, and chemical targeting","volume":"9","author":"Stricher","year":"2013","journal-title":"Autophagy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","article-title":"Nasopharyngeal carcinoma: Current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13046-022-02457-4","article-title":"Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment","volume":"41","author":"Jiang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41591-021-01444-0","article-title":"Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: A multicenter randomized phase 3 trial","volume":"27","author":"Mai","year":"2021","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41420-026-02999-y","article-title":"Harnessing the immune microenvironment: Advances in nasopharyngeal carcinoma immunotherapy","volume":"12","author":"Zhu","year":"2026","journal-title":"Cell Death Discov."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Su, Z.Y., Siak, P.Y., Leong, C.O., and Cheah, S.C. (2023). The role of Epstein-Barr virus in nasopharyngeal carcinoma. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1116143"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:27:28Z","timestamp":1788427648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":28,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172851"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172851","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}